Autocrine and paracrine growth regulation of breast cancer: Clinical implications
- 21 Downloads
Research using experimental models of human breast cancer has broadened our understanding of the possible biochemical pathways regulating breast cancer growth. Breast cancer cells express receptors for and respond to a variety of steroid and polypeptide hormones and growth factors. Specific oncogenes are also expressed in breast cancer cells, and levels of expression may relate to tumor growth and aggressiveness. Recent studies have shown that breast cancer cells can even synthesize and secrete various growth factors that could stimulate tumor growth through autocrine and/or paracrine mechanisms. Secretion of some of these growth factors is regulated by estrogen, providing a possible mechanism for estrogen induced growth. Knowledge of these growth regulatory pathways has potentially important clinical implications. Blockade of these pathways offers new possible treatment strategies, much as antiestrogens have been used to inhibit tumor growth. Quantification of the expression of certain oncogenes, growth factor receptors, or the growth factors themselves, may provide prognostic information for the individual patient. Finally, it is plausible that measurement of these tumor products in body fluids might provide tumor markers that are useful in the diagnosis and treatment of breast cancer.
Key wordsbreast cancer growth factors growth regulation estrogen action
Unable to display preview. Download preview PDF.
- 10.Coronado E, Ramasharma K, Li CH, Kitten L, Marshall M, Fuqua S, Osborne K: Insulin-like growth factor II (IGF-II): A potential autocrine growth factor for human breast cancer (Abstract). Proc Am Assoc Cancer Res 29: 237, 1988Google Scholar
- 12.Osborne CK, Hamilton B, Nover M: Receptor binding and processing of epidermal growth factor by human breast cancer cells. J Clin Endo Metab 55: 86–93, 1982Google Scholar
- 15.Nunez A-M, Jakowlev S, Briand J-P, Gaire M, Krust A, Rio M-C, Chambon P: Characterization of the estrogeninduced pS2 protein secreted by the human breast cancer cell line MCF-7. Endocrinol 121: 1759–1765, 1987Google Scholar
- 30.Arteaga CL, Kitten L, Coronado E, Jacobs S, Kull F, Osborne CK: Blockade of the type I somatomedin receptor inhibits growth of estrogen receptor negative human breast cancer cells in athymic mice (Abstract). Proc 70th Annual Meeting Endocr Soc 191: 683, 1988Google Scholar
- 33.Cuttitta F, Carney DN, Mulshine J, Moody TW, Fedorko J, Fischler A, Minna JD: Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature 823–826, 1985Google Scholar